[ FROM THE FIELD ]
2019 AMERICAN SOCIETY OF HEMATOLOGY
MEETING UPDATES
The Lymphoma Research Foundation (LRF) returned to the American Society of Hematology (ASH) Annual Meeting and Exposition, with nearly 70 LRF-affiliated scientists presenting more than 100 abstracts at this year’s conference. Widely regarded as the premier event in malignant and non-malignant hematology, the ASH Annual Meeting, held from December 7-10, 2019 in Orlando, Fla., provided a critical forum for leading hematologists/oncologists to present their findings to over 30,000 of their peers. Among the distinguished scientists invited to present, nearly 50 percent of LRF Scholars—participants in LRF’s Lymphoma Clinical Mentoring Program— presented abstracts at the 2019 ASH Annual Meeting. In addition to the Lymphoma Research Foundation’s representation through presentations, more than 60 percent of LRF grantees from the past decade were authors on abstracts selected for this year’s meeting alone. In addition, LRF is represented in more than 770 abstracts through grantees, Lymphoma Rounds Steering Committee members, Mantle Cell Lymphoma (MCL) Consortium members, LRF staff, and current and former SAB members. The 2019 ASH Annual Meeting also featured 15 abstracts and presentations stemming from LRF-funded research.
LRF was represented in
770+ ABSTRACTS
15
LRF-FUNDED
research abstracts and presentations
PULSE | WINTER EDITION 2020
“ The fact that we have 98 percent of LRF’s current Scientific Advisory Board (SAB) members involved in abstracts at this year’s ASH Annual Meeting speaks to the caliber of world-leading scientists we have steering LRF’s research investment and patient education.” — Andrew D. Zelenetz, MD, PhD, Chair of the LRF Scientific Advisory Board
60%
OF LRF GRANTEES
over the past decade authored abstracts
98%
OF LRF’S SCIENTIFIC ADVISORY BOARD (SAB) MEMBERS
were involved in abstracts
